A new MPCCC tele-trials pilot project will reduce the need for people with cancer to travel to large metropolitan centres in Melbourne to undertake trial-related visits and procedures. The pilot aims to leverage the significant clinical trials expertise and established resources at Monash Health, to support the development of clinical [...]
Collaborative Research Grants: Improving Cancer Outcomes for Upper Gastrointestinal Cancers Real-time patient-reported outcomes in clinical practice – a novel approach to improving quality of care for patients with upper gastrointestinal cancer ($1,598,233) Investigators: Prof John Zalcberg (Lead Applicant), Dr Liane Ioannou, A/Prof Sue Evans, Prof Madeleine King, Dr Daniel Croagh, Dr [...]
MRFF Fellowships Prof John Zalcberg, Professor of Cancer Research, Department of Epidemiology and Preventive Medicine, Monash University A national cancer outcome strategy ($487,893.00) A/Prof Andrew Wei, Head of Leukaemia Research, Australian Centre for Blood Diseases, Monash University and Alfred Health Translational Research Program to Advance Clinical Outcomes in Acute Myeloid [...]
A network of tumour-specific MPCCC Precision Oncology Tumour Boards will be rolled out across MPCCC partner sites in early 2019 thanks to funding received from the Victorian Cancer Agency. “The primary aim of establishing MPCCC’s network of Precision Oncology Tumour Boards is to integrate the considerable clinical, molecular and research [...]
Cancer patients suffering from depression will be invited to participate in the MPCCC’s shared care pilot program from early 2019, and will have access to high quality psycho-oncology treatment close to where they live. “Clinical depression is the most prevalent psychological condition affecting cancer patients, but many patients do not [...]
MPCCC’s 2018 Cancer Forum dinner at Huntingdale Golf Club on 16 October was a networking event for our partners and stakeholders. Cancer clinicians, health professionals, researchers, administrators, community and government joined us for the occasion. The event was emceed by MPCCC’s Chair, Andrew Way. Speakers included Prof Melissa Southey, [...]
Monash Partners Comprehensive Cancer Consortium (MPCCC) is to pilot an innovative model of care enabling cancer patients with depression to have improved access to psychology services. Research has shown around twenty percent of cancer patients and survivors suffer with clinical depression. If undetected or under-treated, depression can severely impact quality [...]
Cancer patients treated at Monash Partners’ hospitals will have equitable access to the latest precision medicine technologies, and the best medical advice and treatments thanks to a new Precision Oncology Tumour Board, to be established by the Monash Partners Comprehensive Cancer Consortium (MPCCC). Collectively MPCCC partners care for over 19,000 [...]
Professor Andrew Way, Chief Executive, Alfred Health was welcomed as the incoming Chair of MPCCC’s Governance Group on 3 May. Professor Way has served as Alfred Health's Chief Executive since 2009. He is also an Associate Clinical Professor at Monash University’s Faculty of Medicine, Nursing and Health Sciences, Director of [...]
Monash Partners’ Cancer and Blood Diseases theme, the Monash Partners Comprehensive Cancer Consortium (MPCCC), will advance collaborative programs outlined in its 2017 – 2021 strategic plan thanks to new funding provided by the Victorian Department of Health and Human Services (DHHS). The funding was confirmed in mid-April and will include [...]
